Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.

“The projects awarded pilot studies grants for 2026 address important clinical and translational science questions,” says CTSI Director Sanjay Sethi, MD, SUNY Distinguished Professor of medicine and ...

The final, formatted version of the article will be published soon. Hepatocellular carcinoma (HCC) is characterized by pronounced intratumoral heterogeneity and a complex immune microenvironment, ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

The largest single cell perturbation dataset to-date will be generated and released open source in a new team effort.

ILMN's Connected Multiomics, launched after early user input, advances precision health research and may boost the stock.

Smoking tobacco is known to worsen symptoms of periodontitis and reduce responsiveness to treatment. Using high-resolution ...

Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

Illumina, whose EMEA head office is at Granta Park in Cambridge, has released Illumina Connected Multiomics, a powerful cloud ...

Researchers developed two computational tools to decode how cells communicate in tissues. sCCIgen creates realistic virtual ...

The "In Situ Hybridization Market Report by Product, Technique, Application, End User, Countries and Company Analysis ...

Illumina is building the most comprehensive multiomic solutions in the industry, anchored on its world-class sequencing ...